|
|
| Dr. Inaam Hassan | | | Associate Professor | | Department of Internal Medicine | | | Phone: | 971 3 7137 679 | | Fax: | 971 3 7672995 | | Email: | inaambh@uaeu.ac.ae |
College of Medicine and Health Sciences
United Arab Emirates University
P.O.Box 17666, Al-Ain
United Arab Emirates |
| Degree | University | Year |
|---|
| MBBS | University of Khartoum, Sudan | 1981 | | PhD in Pathology | University of Uppsala, Sweden | 1991 |
| | Postgraduate Diplomas, Certificates, and Fellowships | Year |
|---|
| Specialist of Haematology, Swedish National Board | 1998 | | Specialist of Internal MedicineI, Swidish National Board | 2001 | | Specialist in Haematopathology, Uppsala University | 1991 |
| | Appointment | Year |
|---|
| Haematologist/Haematopathologist, Dept Internal Medicine/Dept of Pathology, Umea, Sweden | Feb 1997 - Aug 1999 | | Senir consultant Haematologist, Dept Internal Medicine, Esklistuna, Sweden | Sep 1999 - Aug 2001 | | Senir consultant Haematologist/ Internist, Dept Internal Medicine, Uppsala, Sweden | Sep 2001 - Sept 2005 | | Associate Prof, Dept Internal Medicine, FMHS | Oct 2005 untill now |
| | Research Interests |
|---|
Haematology (benign as well as malignant)
Researsh Interest: Clinical research in acute and chronic leukaemia. Current research projects are:
Retrospective study of clinical and laboratory data of patients with acute leukemia (AL) diagnosed and / or treated at oncology department at Tawam Hospital, AL Ain, UAE between year 2000-2006.
A study for the Use of Multi parameter flow cytometry (MPFC ) for minimal residual disease (MRD) detection in patients with acute leukaemia (AL) Funded from the Interdisciplinary_Grant. UAEU
A study for Immune response versus molecular responses in patients with CML treated with Imatinib Funded from SHEIKH HAMDAN BIN RASHID AL MAKTOUM AWARD FOR MEDICAL SCIENCES
Assessment of Cardiac toxicity in patient with chronic myeloid leukaemia during Imatinib therapy
|
| | Relevant Publications |
|---|
Hassan IB, Gronowitz JS, Carlsson M, Sundström C., alpha-Interferon inhibits spontaneous and induced DNA synthesis in hairy cell leukemia. Leuk Lymphoma. 1992 May;7(1-2):69-77.
Hassan IB, Lantz M, Sundström C. Effect of alpha-IFN on cytokine-induced antigen expression and secretion of TNF, LT and IgM in HCL, Leuk Res. 1991;15(10):903-10.
Hassan IB, Hagberg H, Sundström C., Immunophenotype of hairy-cell leukemia. Eur J Haematol. 1990 Sep;45(3):172-6.
Hassan IB, Sundström C, Hagberg H, Bone marrow morphology during alpha-interferon treatment in hairy cell leukemia., Eur J Haematol. 1989 Aug;43(2):120-6.
PMID: 2792319 [PubMed - indexed for MEDLINE]
Hagberg H, Hassan I, Glimelius B, Gronowitz S, Källander C, Martinsson U, Sundström C. Serum thymidine kinase in hairy cell leukemia before and during treatment with alpha interferon.Haematologica. 1988 Sep-Oct;73(5):365-9. No abstract available.
Sundström G, Löfvenberg E, Hassan I, Engström-Laurent A., Localisation and distribution of hyaluronan in normal bone marrow matrix: a novel method to evaluate impending fibrosis?, Eur J Haematol. 2002 Apr;68(4):194-202.
Mats Carlsson, Inaam Bashir Hassan, Gabriella Paul, Christer Sundström, Kenneth Nilsson and Tomas Tötterman. Hairy cell leukemia (HCL) associated antigen B-ly7 is an activation/differentiation associated antigen on HCL and normal B cells but not on B-type chronic lymphocytic leukemia (B-CLL) cells. Leukemia and Lymphoma 6:133-143, 1992
Inaam Bashir Hassan, Mikael Lantz, Mats Carlsson and Christer Sundström. Induction of DNA synthesis and cytokine secretion (TNF and LT) in hairy cell leukemia by TPA. manuscript to be submitted. |
| |
|
|
